His primary areas of investigation include Cell biology, Immunology, Endoplasmic reticulum, Immune system and Antigen presentation. His Cell biology research is mostly focused on the topic Chaperone. His Immunology study frequently draws parallels with other fields, such as Cytotoxic T cell.
The study incorporates disciplines such as Integrin, Signal transduction, Intracellular and Stromal cell in addition to Endoplasmic reticulum. In his research on the topic of Antigen presentation, MHC class II is strongly related with MHC class I. His work focuses on many connections between T cell and other disciplines, such as Antigen, that overlap with his field of interest in Effector.
His scientific interests lie mostly in Cell biology, Immunology, Immune system, Cancer research and Endoplasmic reticulum. While the research belongs to areas of Cell biology, Zihai Li spends his time largely on the problem of Dendritic cell, intersecting his research to questions surrounding Acquired immune system. Zihai Li studied Immune system and Internal medicine that intersect with Endocrinology.
His Cancer research research is multidisciplinary, incorporating elements of Cancer cell, Cancer, Carcinogenesis, Tumor microenvironment and Cell. His Endoplasmic reticulum research incorporates themes from Hsp90 and Kinase. His Hsp90 research integrates issues from Wnt signaling pathway and Protein folding.
Cancer research, Immune system, Tumor microenvironment, Platelet and T cell are his primary areas of study. His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Cell, Cytokine, CD8 and Cancer immunotherapy. As a part of the same scientific study, Zihai Li usually deals with the Immune system, concentrating on Internal medicine and frequently concerns with Endocrinology.
His Tumor microenvironment research includes themes of Immune checkpoint, Immunotherapy, Oncology, Interferon and Colorectal cancer. His Inhibitory postsynaptic potential research incorporates elements of Intracellular and Cell biology. His research in Cell biology intersects with topics in Sepsis and Bacteria.
Zihai Li mainly focuses on Cancer research, Tumor microenvironment, Cancer, Immunotherapy and Signal transduction. His research investigates the connection between Cancer research and topics such as Platelet that intersect with problems in Receptor, Programmed cell death and Cancer cell. His Cancer study combines topics in areas such as Cell, Jurkat cells, Colitis, Cell growth and Inflammation.
His Immunotherapy research is included under the broader classification of Immune system. Zihai Li combines subjects such as Unfolded protein response, Endoplasmic reticulum, Proteostasis and Secretory pathway with his study of Immune system. His Signal transduction study is focused on Cell biology in general.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor Immunity
Nathalie E. Blachere;Zihai Li;Rajiv Y. Chandawarkar;Ryuichiro Suto.
Journal of Experimental Medicine (1997)
Heat shock proteins transfer peptides during antigen processing and CTL priming
Pramod K. Srivastava;Heiichiro Udono;Nathalie E. Blachere;Zihai Li.
Immunogenetics (1994)
Heat Shock Protein gp96 Is a Master Chaperone for Toll-like Receptors and Is Important in the Innate Function of Macrophages
Yi Yang;Bei Liu;Jie Dai;Pramod K. Srivastava.
Immunity (2007)
Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
Zihai Li;P. K. Srivastava.
The EMBO Journal (1993)
Roles of heat-shock proteins in antigen presentation and cross-presentation.
Zihai Li;Antoine Menoret;Pramod Srivastava.
Current Opinion in Immunology (2002)
Heat-shock proteins.
Zihai Li;Pramod Srivastava.
Current protocols in immunology (2003)
Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo.
Douglas G Millar;Kristine M Garza;Bernhard Odermatt;Alisha R Elford.
Nature Medicine (2003)
Th17 Cells in Cancer: The Ultimate Identity Crisis
Stefanie R. Bailey;Michelle H. Nelson;Richard A. Himes;Zihai Li.
Frontiers in Immunology (2014)
Heat shock protein vaccines against cancer
Nathalie E. Blachere;Heiichiro Udono;Sylvia Janetzki;Zihai Li.
Journal of Immunotherapy (1993)
Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases
Bei Liu;Jie Dai;Hong Zheng;Diliana Stoilova.
Proceedings of the National Academy of Sciences of the United States of America (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Connecticut
Memorial Sloan Kettering Cancer Center
Emory University
Yale University
University of Illinois at Chicago
Medical University of South Carolina
The University of Texas Southwestern Medical Center
Loyola University Chicago
Yale University
Case Western Reserve University
University of Lille
National Institute of Technology Kurukshetra
Central China Normal University
University of Georgia
University of Georgia
Macquarie University
University of Potsdam
Utrecht University
Brigham and Women's Hospital
Rutgers, The State University of New Jersey
The University of Texas at Austin
Augusta University
University of Navarra
University of Cambridge
Norwegian Institute of Public Health
The University of Texas at Austin